Health Services Research and Pharmacy Practice Conference 2023

John Wright is a doctor and epidemiologist with a background in hospital medicine and public health in the UK and in Africa. He established and leads the Bradford Institute for Health Research and Wolfson Centre for Applied Health Research, working to speed up translation of medical research into practice and policy. He is the Director of Research for the City of Bradford and Director of the NIHR Yorkshire and Humber Applied Research Collaboration. He is Visiting Professor in Clinical Epidemiology at the Universities of York, Leeds and Bradford and has authored over 500 papers and three textbooks and been awarded over £150 million in research award funding, £50 million as chief investigator

In 2007 he set up the Born in Bradford (BiB) cohort study which is following the lives of over 13,000 families as their children grow up. Evidence from BiB studies has informed local, national international policies and led to improvements in clinical practice and public health as well as a successful City of Culture award. In 2016 he set up Born in Bradford’s Better Start – the world’s first experimental birth cohort - to test new approaches to providing the best support in the crucial period of early life. In 2019 he established ActEarly to develop a whole systems City Collaboratory approach to improving the health and life chances of children from deprived communities in London and Yorkshire.

He has worked to develop sustainable public health programmes in Africa for 30 years including setting up and running an Ebola Treatment Centre for Doctors of the World in Sierra Leone during the Ebola epidemic. He was the research and scientific lead for Clinical and District Gold command during the COVID19 pandemic and set up the COVID19 Scientific Advisory group (CSAG). He has reported for the BBC on programmes covering Born in Bradford, Ebola and most recently The NHS Frontline podcast.

David Alldred worked as a clinical pharmacist in secondary care for five years before joining the University of Leeds as a research clinical pharmacist conducting a randomised controlled trial of pharmacist-led medication review for care home residents; this research formed the basis of his PhD. Following this, Dave was Lecturer in Pharmacy teaching pharmacology, therapeutics, pharmacy practice, evidence-based medicine, patient safety and medicines partnership.

He was appointed as Senior Lecturer in Pharmacy Practice at Bradford School of Pharmacy in 2013, and in 2015 was awarded the Pharmacy Practice UK Research Award and became a Fellow of the Royal Pharmaceutical Society. Dave was appointed as Associate Professor in Pharmacy Practice at the University of Leeds in 2015 and Professor of Medicines Use and Safety in 2017. He leads the Medicines Optimisation research theme for the School of Healthcare and is also the Deputy Lead for the Safe Use of Medicines theme in the Patient Safety Translational Centre.

His research focuses on improving the use of medicines, particularly for frail, older people including those living in care homes. Dave managed the Care Homes' Use of Medicines study (CHUMS), a UK Department of Health funded national study of medication errors in care homes, which has had a significant on practice and policy. He was a member of the Guideline Development Group for the National Institute for Health and Care Excellence (NICE) Medicines Management in Care Homes Good Practice Guidance. He leads work streams on two NIHR Programme Grants for Applied Research - CHIPPS (testing the effectiveness and cost-effectiveness of pharmacist prescribing in care homes) and ISCOMAT (improving the experiences and outcomes for heart failure patients post-discharge through best use of medicines). David have recently been working with NHS England to implement a national Medicines Optimisation for Care Homes scheme.

Professor Bryony Dean Franklin BPharm BA MSc PhD FRPharmS FFRPS

Professor Bryony Dean Franklin is a hospital pharmacist and Director of the Centre for Medication Safety and Service Quality (CMSSQ), a joint research unit between Imperial College Healthcare NHS Trust and UCL School of Pharmacy, where Bryony is Professor of Medication Safety.  She is a theme lead for both the NIHR Imperial Patient Safety Translational Research Centre and the NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London.

Bryony has been involved with patient safety research for more than 25 years; she has published widely on medication safety, the evaluation of various technologies designed to reduce errors, and the patient’s role in patient safety. Her current post combines research, quality improvement, education and training, and hospital pharmacy practice.  Bryony is Co-Editor-in-Chief for the journal BMJ Quality and Safety. She is also co-editor of the textbook “Safety in Medication Use” and co-author of “Going into Hospital?  A guide for patients, carers and families”, a book aimed at the general public. In addition to her paid work, she is a Church of England parish priest. 

Amir M. Sharif is the Dean of the Faculty of Management, Law and Social Sciences and Professor of Circular Economy. Starting his academic career as a researcher within the field of artificial intelligence, Amir rapidly developed his research interests to apply his knowledge to addressing complex societal challenges in the areas of food security, circular economy, healthcare, operations / supply chain management, decision-making and humanitarian logistics. His specific area of interest is in the application of systems thinking, causal and cognitive models to explore human decision-making behaviours in complex environments

Amy Booth is a medical doctor and PhD candidate at the University of Oxford. Her interest in sustainable health care developed when she was working during the pandemic and noticed how environmentally polluting health care provision could be. She became particularly concerned by the significant contribution of pharmaceuticals to the NHS's carbon footprint and her research looks at how to reduce the greenhouse gas emissions of the pharmaceutical supply chain.

Peter is Medicines Net Zero Assistant Director for NHS England. The Medicines Net Zero team are working to reduce the environmental impact of the medicines used across the NHS in England. The team forms part of the Greener NHS programme, based within the Medicines Policy and Analysis Unit and combining environmental policy with medicines usage and supply. As a registered pharmacist, Peter previously worked in secondary care and primarily in aseptic services and clinical nutrition. He most recently led the aseptic service at King’s College Hospital NHS Foundation Trust as associate chief pharmacist, where he also led the equality, diversity and inclusion and sustainability work for the department. Peter undertook the Chief Pharmaceutical Officer's Clinical Fellowship scheme in 2018/19, where he formed the syllabus for the community pharmacy consultation service course and acted as a subject matter expert for a level 4 Emergency Preparedness, Resilience and Response incident. Peter also cofounded Pharmacy Declares, a group of climate conscious pharmacy professionals based in the United Kingdom.

Costas is a Pharmacist in the Bradford District and Craven Health and Care Partnership Medicines Optimisation Team. Within my role I chair the West Yorkshire (WY) Pharmacy Network for Sustainability and the Environment. A network within WY pharmacy which brings together colleagues from a variety of organisations, sectors and roles who wish to work together on reducing the environmental impact of pharmacy, medicines, and other associated products. I continue to work to embed sustainability into WY pharmacy to improve both the immediate and long-term health of our population.